Literature DB >> 8093417

Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy.

J W Bekenstein1, E W Lothman.   

Abstract

In humans temporal lobe epilepsy (TLE) is characterized by recurrent seizures, neuronal hyperexcitability, and selective loss of certain neuronal populations in the hippocampus. Animal models of the condition indicate that a diminution of inhibition mediated by gamma-aminobutyric acid (GABA) accounts for the altered function, and it has been hypothesized that the diminution arises because GABAergic basket interneurons are "dormant" as a result of their being disconnected from excitatory inputs. In hippocampal slices, inhibitory postsynaptic potentials (IPSPs) were elicited in CA1 pyramidal cells by activation of basket cells; responses from an animal model of TLE were compared to those from control tissue. IPSPs evoked indirectly by activation of terminals that then excited basket cells were reduced in the epileptic tissue, whereas IPSPs evoked by direct activation of basket cells, when excitatory neurotransmission was blocked, were not different from controls. These results provide support for the "dormant basket cell" hypothesis and have implications for the pathophysiology and treatment of human TLE.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093417     DOI: 10.1126/science.8093417

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  39 in total

1.  Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment.

Authors:  J L Hellier; P R Patrylo; P Dou; M Nett; G M Rose; F E Dudek
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

2.  Testing the disinhibition hypothesis of epileptogenesis in vivo and during spontaneous seizures.

Authors:  P S Buckmaster; A L Jongen-Rêlo; S B Davari; E H Wong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Operative GABAergic inhibition in hippocampal CA1 pyramidal neurons in experimental epilepsy.

Authors:  M Esclapez; J C Hirsch; R Khazipov; Y Ben-Ari; C Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulation-based animal model of temporal lobe epilepsy.

Authors:  Chengsan Sun; Zakaria Mtchedlishvili; Edward H Bertram; Alev Erisir; Jaideep Kapur
Journal:  J Comp Neurol       Date:  2007-02-10       Impact factor: 3.215

5.  A comparison of the efficacy of carbamazepine and the novel anti-epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy.

Authors:  H C Doheny; M A Whittington; J G R Jefferys; P N Patsalos
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

6.  Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus.

Authors:  J Doherty; R Dingledine
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

7.  Epileptic activity outlasts disinhibition after intrahippocampal tetanus toxin in the rat.

Authors:  M A Whittington; J G Jefferys
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

Review 8.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

9.  The mechanism of abrupt transition between theta and hyper-excitable spiking activity in medial entorhinal cortex layer II stellate cells.

Authors:  Tilman Kispersky; John A White; Horacio G Rotstein
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

10.  Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.

Authors:  Laxmikant S Deshpande; Robert E Blair; Nisha Nagarkatti; Sompong Sombati; Billy R Martin; Robert J DeLorenzo
Journal:  Exp Neurol       Date:  2007-01-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.